Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | HRH3 | Q9Y5N1 | 5/20 | 0.45 |
| ▸ | CTSK | P43235 | 1/20 | 0.41 |
| ▸ | KIF11 | P52732 | 3/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.40 |
| ▸ | MMP3 | P08254 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | ICMT | O60725 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16941078 | 0.87 | TSHR (0.53) | TSHRHSD17B10HRH3KIF11CYP2A6 | |
| SCHEMBL13699919 | 0.86 | CYP2A6 (0.47) | TSHRHSD17B10HRH3KIF11CYP2A6 | |
| SCHEMBL15905720 | 0.86 | MEN1 (0.44) | TSHRHSD17B10CTSKCYP2A6ALDH1A1 | |
| SCHEMBL16922706 | 0.84 | KIF11 (0.44) | TSHRHSD17B10HRH3KIF11CYP2A6 | |
| SCHEMBL3997043 | 0.81 | MMP3 (0.46) | TSHRHSD17B10HRH3KIF11CYP2A6 | |
| SCHEMBL455471 | 0.79 | MAPT (0.40) | HSD17B10ALDH1A1GAA | |
| SCHEMBL26991561 | 0.77 | TSHR (0.43) | TSHRHSD17B10HRH3KIF11CYP2A6 | |
| SCHEMBL29084017 | 0.76 | TSHR (0.42) | TSHRHSD17B10HRH3CTSKKIF11 | |
| SCHEMBL10304732 | 0.76 | KIF11 (0.50) | TSHRHSD17B10HRH3CTSKKIF11 | |
| SCHEMBL2154771 | 0.76 | CYP2A6 (0.44) | CYP2A6ALDH1A1CYP11B2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090184631-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090184631-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | ALDH1A2, ODC1, NDUFS2 | TSHR 4731/4885HSD17B10 768/4885HRH3 3743/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.